Conflicts of Interests Statement 2016-2017

The COPD Guidelines Committee is responsible for updating the COPD-X Guidelines. All below-named members of the COPD Guidelines Committee are required to lodge declarations of potential conflicts of interest with Lung Foundation Australia on an annual basis. Such disclosures include the receipt of unrestricted educational grants, sponsorship, consultancy or other affiliations with the pharmaceutical, medical equipment or diagnostic industries.

Conflicts of Interest Declarations 2017

Committee Member

Conflict of interest declaration

Professor Ian Yang, Thoracic Physician, The Prince Charles Hospital and The University of Queensland, Brisbane, QLD (Chair) Dr Yang declares that he has received travel and accommodation sponsorship several times to speak at or participate in educational meetings, which have been organised by an independent organising committee and sponsored by industry.

He has accepted hospitality in connection with evening professional educational meetings organised by pharmaceutical companies.

Dr Yang is involved with the National COPD Executive of the Lung Foundation Australia (not-for-profit, public benevolent institution) (www.lungfoundation.com.au) which receives some support from pharmaceutical companies.

Dr Yang has been involved in organising and participating in professional scientific meetings including those organised by the Thoracic Society of Australia and New Zealand, where some sponsorship is usually provided by industry.

Dr Yang declares that he has not received consultancy fees or honoraria from pharmaceutical companies, and has not acted as a member of advisory boards for pharmaceutical companies.

Dr Yang is an employee of The Prince Charles Hospital, Metro North Hospital and Health Service, Queensland Health and The University of Queensland.

Dr Yang is a Board member of the Asthma Foundation Queensland NSW, and Chair of its Medical, Programs and Research Advisory Committee.

His institutions have received project grants and fellowships from the following sources:
– National Health and Medical Research (NHMRC)
– Queensland Government Health and Medical Research project grants
– The Prince Charles Hospital Foundation
– Australian Research Council (ARC) Discovery Grant
– Australian Respiratory Council Harry Windsor Project Grant
– Faculty of Medicine, The University of Queensland
– Australian Cancer Research Foundation

He is on the editorial boards of Respirology, Annals of Internal Medicine, Respiratory Medicine Today and the Cochrane Airways Group.

Dr Eli Dabscheck,  Staff Specialist, Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, VIC (Deputy Chair) No conflicts to declare
Dr Johnson George, Senior Lecturer, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC Dr Johnson George is chief investigator on a NHMRC Partnership Project ‘RADICALS’. The RADICALS study receives in-kind support from its partnership organisations: Lung Foundation Australia (LFA), Boehringer Ingelheim Pty Ltd (BI) and Eastern Melbourne Primary Health Network (EMPHN). Dr George has held investigator-initiated research grants from Pfizer and BI. Dr George has received in-kind support from Vitalograph, the manufacturers of COPD-6.
Associate Professor Sue Jenkins, Institute for Respiratory Health; Physiotherapy Department, Sir Charles Gairdner Hospital; Adjunct Professor, School of Physiotherapy and Exercise Science, Curtin University, Perth, WA Member of Menarini COPD Advisory Board
Professor Christine McDonald, Director, Department of Respiratory and Sleep Medicine, Austin Hospital, Melbourne, VIC Receive occasional honoraria for Pharma talks <$3000 per annum
Professor Vanessa McDonald, Professor of Chronic Disease Nursing, Centre for Healthy Lungs, School of Nursing and Midwifery, The University of Newcastle; Academic Clinician, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW Advisory board and speaker fees <$10,000 total for Menarini, AZ, GSK
Professor Brian Smith,  Thoracic Physician, The Queen Elizabeth Hospital, Adelaide, SA No conflicts to declare
Professor Nick Zwar,  Professor of General Practice, School Public Health & Community Medicine, Faculty of Medicine, University of New South Wales, Sydney NSW No conflicts to declare

Conflicts of Interest Declarations 2016

Committee Member

Conflict of interest declaration

Professor Ian Yang, Thoracic Physician, The Prince Charles Hospital and The University of Queensland, Brisbane, QLD (Chair) The following are appointments, grants, Fellowships or other areas of involvement that are not actual conflicts of interest, but should be declared:

Dr Yang is an employee of Metro North Hospital and Health Service and The University of Queensland. Dr Yang declares that he has not received consultancy fees or honoraria from pharmaceutical companies, and has not acted as a member of advisory boards for pharmaceutical companies.

Dr Yang declares that in the last 3 years, he has:

– Given COPD presentations (all his own slides) at educational meetings organised by pharmaceutical companies (Boehringer Ingelheim, Novartis, AstraZeneca) – in all instances, he donated the honorarium, if any.

– Accepted hospitality in connection with attending evening professional educational meetings organised by pharmaceutical companies.

Dr Yang is Chair of the National COPD Guidelines Committee of Lung Foundation Australia (www.lungfoundation.com.au). This not-for-profit public benevolent institution receives grant support from pharmaceutical and other industry companies (Boehringer Ingelheim, Novartis, GSK, AstraZeneca, Air Liquide, Menarini) towards its National COPD Program.

Dr Yang is a Board member of the Asthma Foundation Queensland NSW, and recent Chair of its Medical, Programs and Research Advisory Committee. In the last 3 years, his institutions have received project grants and fellowships from the following sources: National Health and Medical Research (NHMRC) project grants – NHMRC Career Development Fellowship; Cancer Council Queensland project grants; Queensland Government Health and Medical Research project grants; The Prince Charles Hospital Foundation; AusHSI; Australian Research Council (ARC) Discovery Grant; Australian Respiratory Council Harry Windsor grant; School of Medicine, The University of Queensland; Australian Cancer Research Foundation; Novartis – one year (2013) unrestricted grant to establish a severe asthma service at The Prince Charles Hospital (paid to The Prince Charles Hospital Fundation, for use by the hospital).

He is on the editorial boards of Respirology, Annals of the American Thoracic Society and the Cochrane Airways Group. List of clinical studies: Boehringer Ingelheim: DYNAGITO study (Aug 2015 onwards). Local site investigator in this international study. Clinical department supported by Boehringer Ingelheim for each participant enrolled.

 

Dr Eli Dabscheck,  Staff Specialist, Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, VIC (Deputy Chair) No conflicts to declare
Dr Johnson George, Senior Lecturer, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC I have received in-kind support from Vitalograph, the manufacturers of COPD-6, for an unrelated project focusing on telehealth of asthma in pregnancy. I have held investigator-initiated research grants from Pfizer for a project focusing on pharmacist-initiated smoking cessation support for in-patients. A study co-funded by Boehringer Ingelheim is currently underway focusing on early diagnosis of COPD in long-term smokers. Both these studies were developed by myself in collaboration with co-investigators. Pfizer and BI neither had any role in setting the study objectives nor will be involved in the analysis or publication of the study findings.
Associate Professor Sue Jenkins, Institute for Respiratory Health; Physiotherapy Department, Sir Charles Gairdner Hospital; Adjunct Professor, School of Physiotherapy and Exercise Science, Curtin University, Perth, WA Member of the COPD Advisory Board (Menarini)

Sponsored to attend Astra Zeneca Respiratory Summit meeting (Feb 2016)

Honoraria for presentations on behalf of Astra Zeneca Honoraria for presentations on behalf of Boehringer Ingelheim

Sponsored to attend Boehringer Ingelheim AIRWAYS 2016 meeting.

Professor Christine McDonald, Director, Department of Respiratory and Sleep Medicine, Austin Hospital, Melbourne, VIC I sit on occasional Advisory Boards for Pfizer,Novartis. Have spoken at meetings with speaker fees- GSK, Novartis.

Medical Director – Institute for Breathing and Sleep,  Heidelberg Vic

Professor Vanessa McDonald, Professor of Chronic Disease Nursing, Centre for Healthy Lungs, School of Nursing and Midwifery, The University of Newcastle; Academic Clinician, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW Advisory board membership – GSK, AZ, Menarini, and Novartis
Professor Brian Smith,  Thoracic Physician, The Queen Elizabeth Hospital, Adelaide, SA No conflicts to declare
Professor Nick Zwar,  Professor of General Practice, School Public Health & Community Medicine, Faculty of Medicine, University of New South Wales, Sydney NSW No conflicts to declare

NOTE: Conflicts of Interest correct at January 2017